Tarsus Pharmaceuticals Q3'26 Earnings Preview: EPS Estimate (1.46)
Tarsus Pharmaceuticals is scheduled to report Q3'26 results on November 03 after the market closes. Revenue is estimated at 187.83 million USD and EPS at (1.46) USD.
Related stories
NAPCO Shares Fall 17.2% After Q1 Revenue Miss
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
German Traffic Systems Shares on Track for Worst Day in 25 Years After Outlook Cut
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Kosmos Energy shares fall 13% after Q3 revenue miss
Kosmos Energy shares are down 13% after the company missed revenue expectations for the third quarter.
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Truckers Maintain Strike, Block Container Access at San Antonio Port
Truckers are maintaining a strike and blocking container access at San Antonio ahead of Chile’s peak cherry-export season.
M impact | EQUITY | Nov 02, 2026, 02:43 PM UTC
Twin Disc Maintains Quarterly Dividend at $0.05 per Share
Twin Disc kept its quarterly dividend at $0.05 per share, payable Dec. 1 to holders of record Nov. 18.
M impact | EQUITY | Nov 02, 2026, 02:42 PM UTC
Ryanair CEO Sees European Airfares Rising Up to 20% Next Year
Ryanair’s CEO expects European plane ticket prices may climb as much as 20% next year, with jet fuel prices rising.
L impact | EQUITY | Nov 02, 2026, 02:42 PM UTC